This HTML5 document contains 211 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n9http://dx.doi.org/10.1210/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33736093
rdf:type
wikibase:Item
schema:description
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած სამეცნიერო სტატია επιστημονικό άρθρο vitenskapelig artikkel мақолаи илмӣ سائنسی مضمون artigo científico (publicado na 2009) מאמר מדעי 2009年论文 мақолаи илмӣ artigo científico مقالهٔ علمی tieteellinen artikkeli 2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված videnskabelig artikel (udgivet 2009) artículu científicu espublizáu en 2009 2009年論文 2009年论文 artículo científico publicado en 2009 article scientifique (publié 2009) wetenschappelijk artikel vetenskaplig artikel 2009年の論文 2009年论文 artikull shkencor tudományos cikk wissenschaftlicher Artikel article scientific vědecký článek مقالة علمية 2009 nî lūn-bûn 2009年论文 научна статия наукова стаття, опублікована в грудні 2009 mokslinis straipsnis 2009년 논문 teaduslik artikkel 2009年論文 scienca artikolo 2009年論文 บทความทางวิทยาศาสตร์ scientific article naučni članak vedecký článok 2009年論文 2009年论文 articolo scientifico artikulong pang-agham научни чланак artigo científico (publicado na 2009) научни чланак vitskapeleg artikkel articol științific 2009年论文 article científic научная статья artykuł naukowy bài báo khoa học bilimsel makale ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2009年論文
p:P577
wds:Q33736093-1083C859-02E8-4367-A565-8A57CD7BEF08
wdt:P577
2009-12-04T00:00:00Z
p:P407
wds:Q33736093-C6D4FE13-D8E0-4B9A-AC29-C0CB82F54F65
wdt:P407
wd:Q1860
p:P2860
wds:Q33736093-D51CAD3B-C3B7-43F1-B712-37F920449DDC wds:Q33736093-D930F41D-FEC1-4177-A664-401C5D84D426 wds:Q33736093-DB2E5DF4-7C5C-4722-94E7-7F75C0015C62 wds:Q33736093-DDEE16CE-D7AB-45B6-911E-34FB8CE6A70D wds:Q33736093-FD9050AD-0BD8-4941-BF48-164A014EB33B wds:Q33736093-926C45D0-24F2-460A-8BFB-E04910E94019 wds:Q33736093-954E4843-A171-4B15-A7D8-597DC423CC4A wds:Q33736093-980E1E1E-EBD4-4BED-AD56-E8244927BDCB wds:Q33736093-9B1BAB19-360A-418D-831F-F027B422F0F8 wds:Q33736093-9D962E3F-EED5-49DC-8D61-EFE7C094B080 wds:Q33736093-AFC8FDDE-CF1B-40F7-85CD-8F6793FC3E38 wds:Q33736093-B3A020FF-E17E-4F20-AFC3-E596DB4F1E16 wds:Q33736093-B65BDE59-533C-45A2-9F84-4594C9CDBFE1 wds:Q33736093-BD91B320-5546-41B6-851A-3D30DD755D51 wds:Q33736093-C17B142B-B5ED-467D-83E4-0F55CD57322C wds:Q33736093-CEDD872C-7999-4876-8CE1-6B5AAA005802 wds:Q33736093-D3D87512-75B2-49FA-985D-9179EDA5861F wds:Q33736093-51EBA083-9ACB-4D56-8FC9-26B77D171CBB wds:Q33736093-591E448F-9059-4C4C-9C1C-C48BF2513D56 wds:Q33736093-5C2A9ADC-A25F-41ED-90CF-1D332DCF3585 wds:Q33736093-6245A820-DFA4-4F63-B987-5942D83A0113 wds:Q33736093-6BF13AD3-9042-4923-9434-B13C194EFB1B wds:Q33736093-713C8720-4193-44EC-BDDD-030486853517 wds:Q33736093-7AF00FB7-F771-407F-A3A3-ABC86A6C05CF wds:Q33736093-82AF9FC5-C609-4441-881A-146CC083D92E wds:Q33736093-89EE6944-1AA9-406F-8DCD-002E23C2CDC6 wds:Q33736093-8BE8EFC5-7EBF-4D9D-BBAF-3214B4BB3A48 wds:Q33736093-8E621200-DFA8-4CCC-890F-A1366F53D18B wds:Q33736093-1F80C37F-1860-4D7D-B063-42A6175B6A53 wds:Q33736093-2172A9F8-4715-41A0-B905-0386BAC459C1 wds:Q33736093-264EDD98-CE65-43C5-8FEC-7F70794B51E3 wds:Q33736093-2EA59989-78B0-467D-A954-2DE925FECDFB wds:Q33736093-32D91424-DF7C-49E6-9FC9-D559FFA07574 wds:Q33736093-360B4942-AFB4-4E9D-9F43-8D95A9770E76 wds:Q33736093-3BB4C8FB-1890-4ED8-99BD-237EEE63D9ED wds:Q33736093-42385848-9D87-41ED-A79D-B91ECE2882F4 wds:Q33736093-447F76E6-B0D2-49D3-A8CB-0C99BBFBE843 wds:Q33736093-467DFE96-6F06-416E-AC37-62FD92CA545D wds:Q33736093-4B33C41F-10BA-491D-8CDC-098A92A79E4E wds:Q33736093-510DC7EF-11D8-4712-AA76-8F10AB5F7A5D wds:Q33736093-000882C9-154C-43E2-9A09-55534A12331C wds:Q33736093-00C80729-8ECC-4791-B650-B8A36E8704EB wds:Q33736093-0272315C-D578-4564-BD44-28957AF379B0 wds:Q33736093-1AA6D0A8-9CCA-4FA5-9C56-BCB772CC4A68 wds:Q33736093-1CB8F308-5587-4789-8E85-3655EB685EFF wds:Q33736093-1F60D971-0043-4473-8AF9-9D32B974F790
wdt:P2860
wd:Q38322297 wd:Q35728669 wd:Q53661245 wd:Q33974129 wd:Q44203982 wd:Q53964449 wd:Q45187805 wd:Q81425267 wd:Q37364983 wd:Q59575076 wd:Q73804043 wd:Q28575122 wd:Q24319751 wd:Q74526361 wd:Q34017373 wd:Q35020697 wd:Q33932297 wd:Q34557934 wd:Q24623628 wd:Q44414604 wd:Q28141252 wd:Q46123508 wd:Q28260847 wd:Q54943458 wd:Q36667038 wd:Q46444314 wd:Q77189206 wd:Q37106569 wd:Q37042195 wd:Q34227442 wd:Q44465622 wd:Q40482177 wd:Q40532892 wd:Q28209679 wd:Q24290481 wd:Q34075026 wd:Q40408400 wd:Q28142759 wd:Q28272505 wd:Q28587100 wd:Q60139960 wd:Q34907022 wd:Q51535459 wd:Q50144395 wd:Q46035991 wd:Q40164192
p:P2093
wds:Q33736093-15E748C0-2CB1-4F43-993F-EBD8C6D6968B wds:Q33736093-3AFD082B-F3AC-487B-A653-00441C640B30 wds:Q33736093-778B9FC7-C3B5-4D06-B049-AADE3560CC3D wds:Q33736093-5336EEAD-C248-4C77-B8CF-2B57A02942FD wds:Q33736093-818BB661-66CC-491F-B111-2128D2650E01
wdt:P2093
Takashi Shimada Yuji Yamazaki Tamara Isakova Itaru Urakawa Michael Epstein
rdfs:label
Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active
skos:prefLabel
Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active
schema:name
Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active
p:P50
wds:Q33736093-D159DA95-231B-47C7-8BDB-AB67AA7C9EFF wds:Q33736093-F5D1ED9B-5256-4CB3-B4C3-DB57561DEB35 wds:Q33736093-3F19ACC9-03E7-4F57-A999-A24C2360F0B3 wds:Q33736093-02DA76DC-8325-4DB5-A065-4B0D147EC55C
wdt:P50
wd:Q16875265 wd:Q103034311 wd:Q91116094 wd:Q90101213
p:P1476
wds:Q33736093-04D2E770-3287-45B4-9A50-7483D1A8F6F5
wdt:P1476
Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active
p:P304
wds:Q33736093-0BD387A9-0F92-46EA-84E2-86276D665D96
wdt:P304
578-585
p:P31
wds:Q33736093-8BACE629-0FC6-409C-B5E0-4E75D8D433B1
wdt:P31
wd:Q13442814
p:P921
wds:Q33736093-3DDE1C90-4EF9-476C-9E57-5122270A9B5D wds:Q33736093-396F0A4D-C656-482C-AAEF-67FE90B81751 wds:Q33736093-90CAF33C-3A97-44A5-A698-2A4BDCB31156
wdt:P921
wd:Q1756474 wd:Q1054718 wd:Q202301
p:P698
wds:Q33736093-F94A88C6-8101-4AA4-BD1E-27F6EAB8D29D
wdtn:P698
n12:19965919
wdt:P698
19965919
p:P1433
wds:Q33736093-CA2A57F5-34FF-49E0-AE7F-B1FA3C1CB90C
wdt:P1433
wd:Q3186902
p:P433
wds:Q33736093-09122612-F8CB-45E9-8600-F7FC32141ADE
p:P478
wds:Q33736093-1D492148-45FD-4BF4-88C0-E4EB48127D8D
wdt:P433
2
wdt:P478
95
p:P356
wds:Q33736093-FDBADDEF-9163-43CD-9075-4E5181C8CCF1
wdtn:P356
n9:JC.2009-1603
wdt:P356
10.1210/JC.2009-1603
p:P932
wds:Q33736093-B7A58BB4-7ED7-4AD3-A228-1761A5708F48
wdt:P932
2840849